Parametric Portfolio Associates’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.38M Buy
60,489
+18,054
+43% +$475K ﹤0.01% 2619
2021
Q4
$1.58M Buy
42,435
+10,618
+33% +$456K ﹤0.01% 2586
2021
Q3
$1.35M Buy
31,817
+12,994
+69% +$626K ﹤0.01% 2664
2021
Q2
$838K Sell
18,823
-231
-1% -$8.14K ﹤0.01% 2850
2021
Q1
$686K Buy
19,054
+13,508
+244% +$534K ﹤0.01% 3338
2020
Q4
$221K Buy
+5,546
New +$189K ﹤0.01% 3729

Other funds holding BLFS

Parametric Portfolio Associates's BLFS Position: Q1 2022 in Review

Parametric Portfolio Associates increased its BioLife Solutions (BLFS) stake by 43% in Q1 2022, buying an estimated $475K and bringing the position to 60,489 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Parametric Portfolio Associates first reported a position in BLFS in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.58M in Q4 2021. 164 funds tracked by Wall St. Rank hold BLFS as of Q1 2022.

  • Parametric Portfolio Associates held 60,489 shares of BioLife Solutions worth $1.38M as of Q1 2022.
  • Parametric Portfolio Associates bought 18,054 BioLife Solutions shares in Q1 2022, an estimated $475K.
  • BioLife Solutions made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2619 holding.
  • Parametric Portfolio Associates first reported a position in BioLife Solutions in Q4 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's BioLife Solutions position peaked at $1.58M in Q4 2021.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.